ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,314.67
0.04%
Dow Jones
43,914.12
0.00%
Gold vs US Dollar
2,669.02
-0.44%
Brent Oil
73.595
0.53%
Bitcoin
99,971.61
-0.09%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neorx (MM) (NERX)

  7. Neorx (MM) (NERX) News

Neorx (NERX)

Neorx (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NERX
DateTimeSourceHeadlineSymbolCompany
19/06/200612:30PR Newswire (US)Poniard Pharmaceuticals Announces Name Change Effective and Highlights Targeted Objectives for Picoplatin Clinical ProgramNASDAQ:NERX
07/06/200613:00PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Announces Participation in Pacific Growth Equities 2006 Life Sciences Growth ConferNASDAQ:NERXNeorx (MM)
01/06/200613:00PR Newswire (US)Onmark Signs Contracts with Two Additional Pharmaceutical Manufacturers and Enrolls 1,800 MembersNASDAQ:NERX
31/05/200613:00PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Announces Treatment of First Patient With Picoplatin in Phase 1/2 Front-Line ProstaNASDAQ:NERXNeorx (MM)
15/05/200621:15PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Reports First Quarter Financial ResultsNASDAQ:NERXNeorx (MM)
10/05/200613:00PR Newswire (US)NeoRx Initiates Clinical Trial of Picoplatin in Colorectal Cancer and Announces Name Change to Poniard Pharmaceuticals and ReloNASDAQ:NERXNeorx (MM)
08/05/200613:00PR Newswire (US)NeoRx Announces Participation in Upcoming ConferencesNASDAQ:NERXNeorx (MM)
03/05/200613:00PR Newswire (US)NeoRx to Host Conference Call on May 10 to Provide Corporate and Picoplatin Clinical Development UpdatesNASDAQ:NERXNeorx (MM)
27/04/200613:00PR Newswire (US)NeoRx Closes $65 Million Financing TransactionNASDAQ:NERXNeorx (MM)
25/04/200617:30PR Newswire (US)NeoRx Shareholders Approve Financing TransactionNASDAQ:NERXNeorx (MM)
25/04/200613:00PR Newswire (US)NeoRx Expands Picoplatin Lung Cancer Clinical Trial Into Selected Eastern European CountriesNASDAQ:NERXNeorx (MM)
11/04/200617:13PR Newswire (US)NeoRx Adjourns Special Meeting of ShareholdersNASDAQ:NERXNeorx (MM)
08/03/200621:55PR Newswire (US)NeoRx Corporation's Auditors Expressed Going-Concern QualificationNASDAQ:NERXNeorx (MM)
07/03/200613:00PR Newswire (US)NeoRx Mails Definitive Proxy Statement for Special Shareholder Meeting Set for April 11, 2006NASDAQ:NERXNeorx (MM)
01/03/200621:15PR Newswire (US)NeoRx Reports Fourth Quarter and Full Year Financial ResultsNASDAQ:NERXNeorx (MM)
23/02/200613:00PR Newswire (US)NeoRx Corporation Regains Compliance With Nasdaq Minimum Bid Listing RequirementNASDAQ:NERXNeorx (MM)
01/02/200623:10PR Newswire (US)NeoRx Signs Definitive Agreement for $65 Million Private FinancingNASDAQ:NERXNeorx (MM)
12/01/200601:00PR Newswire (US)NeoRx Receives Notice From Nasdaq Regarding Minimum Bid Price RuleNASDAQ:NERXNeorx (MM)
10/11/200513:01PR Newswire (US)NeoRx Announces Orphan Drug Designation for Picoplatin for Treatment of Small Cell Lung CancerNASDAQ:NERXNeorx (MM)
09/11/200521:05PR Newswire (US)NeoRx Reports Third Quarter 2005 Financial ResultsNASDAQ:NERXNeorx (MM)
01/11/200513:01PR Newswire (US)NeoRx to Present at Rodman & Renshaw Techvest Healthcare ConferenceNASDAQ:NERXNeorx (MM)
11/10/200513:01PR Newswire (US)NeoRx to Present at BIO InvestorForum 2005NASDAQ:NERXNeorx (MM)
27/09/200521:11PR Newswire (US)NeoRx Corporation Regains Compliance with Nasdaq Minimum Bid Listing RequirementNASDAQ:NERXNeorx (MM)
09/08/200521:18PR Newswire (US)NeoRx Reports Second Quarter 2005 Financial ResultsNASDAQ:NERXNeorx (MM)
04/08/200512:30PR Newswire (US)NeoRx Joins The Scripps Research Institute in First Scientific Collaboration at Scripps FloridaNASDAQ:NERXNeorx (MM)
11/07/200514:56PR Newswire (US)NeoRx Announces Treatment of First Patient With Picoplatin in Phase 2 Clinical Trial in Small Cell Lung CancerNASDAQ:NERXNeorx (MM)
27/06/200513:00PR Newswire (US)NeoRx Appoints David A. Karlin, M.D., as Senior Vice President of Clinical Development and Regulatory AffairsNASDAQ:NERXNeorx (MM)
16/06/200513:01PR Newswire (US)NeoRx CEO to Participate in Break-Out Session at Upcoming BIO 2005 ConferenceNASDAQ:NERXNeorx (MM)
10/05/200521:05PR Newswire (US)NeoRx Reports First Quarter Financial ResultsNASDAQ:NERXNeorx (MM)
06/05/200521:15PR Newswire (US)NeoRx Refocusing Resources to Expedite Development of PicoplatinNASDAQ:NERXNeorx (MM)
 Showing the most relevant articles for your search:NASDAQ:NERX

Your Recent History

BIT
UC59VA
Unicredit Bank
BIT
UC8VLG
Unicredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved